Hepatic lipase treatment of chylomicron remnants increases exposure of apolipoprotein EBRASAEMLE, D. L; CORNELY-MOSS, K; BENSADOUN, A et al.Journal of lipid research. 1993, Vol 34, Num 3, pp 455-465, issn 0022-2275Article

After chylomicron remnants, what is left?LUFT, F. C.Journal of molecular medicine (Berlin. Print). 2004, Vol 82, Num 7, pp 411-413, issn 0946-2716, 3 p.Article

Chylomicrons and chylomicron remnants in coronary artery disease: a case-control studySIMONS, L. A; DWYER, T; ROY, P et al.Atherosclerosis. 1987, Vol 65, Num 1-2, pp 181-189, issn 0021-9150Article

In vitro clearance of chylomicron triglycerides containing (w3) eicosapentaenoateCHEN, I. S; SHEPPARD, A. J; CASSIDY, M. M et al.Atherosclerosis. 1987, Vol 65, Num 3, pp 193-198, issn 0021-9150Article

Isolation of serum chylomicrons prior to density gradient ultracentrifugation of other serum lipoprotein classesTERPSTRA, A. H. M.Analytical biochemistry. 1985, Vol 150, Num 1, pp 221-227, issn 0003-2697Article

Chylomicronemia induced by cimetidineIVERIUS, P.-H; BRUNZELL, J. D.Gastroenterology (New York, NY. 1943). 1985, Vol 89, Num 3, pp 664-666, issn 0016-5085Article

A proposed model for the assembly of chylomicronsMAHMOOD HUSSAIN, M.Atherosclerosis. 2000, Vol 148, Num 1, pp 1-15, issn 0021-9150Article

Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein : further evidence supporting the importance of direct binding of remmant lipoproteins to HSPGZHONG-SHENG JI; MAHLEY, R. W.Arteriosclerosis and thrombosis. 1994, Vol 14, Num 12, pp 2025-2032, issn 1049-8834Article

Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II : The genetic basis of lipoprotein disordersFOJO, S. S; BREWER, H. B.Journal of internal medicine. 1992, Vol 231, Num 6, pp 669-677, issn 0954-6820Article

Characterization of chylomicron remnant clearance by retinyl palmitate label in normal humansBERR, F.Journal of lipid research. 1992, Vol 33, Num 6, pp 915-930, issn 0022-2275Article

Molecular and metabolic basis for the metabolic disorder normotriglyceridemic abetalipoproteinemiaHARDMAN, D. A; PULLINGER, C. R; HAMILTON, R. L et al.The Journal of clinical investigation. 1991, Vol 88, Num 5, pp 1722-1729, issn 0021-9738Article

Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defectsRUBINSZTEIN, D. C; COHEN, J. C; BERGER, G. M et al.The Journal of clinical investigation. 1990, Vol 86, Num 4, pp 1306-1312, issn 0021-9738Article

Fat macroglobule formation from chylomicrons and non-traumatic fat embolismHULMAN, G.Clinica chimica acta. 1988, Vol 177, Num 2, pp 173-178, issn 0009-8981Article

Postprandial lipemia as a cardiometabolic risk factorPIRILLO, Angela; NORATA, Giuseppe Danilo; CATAPANO, Alberico Luigi et al.Current medical research and opinion. 2014, Vol 30, Num 8, pp 1489-1503, issn 0300-7995, 15 p.Article

Dietary interventions affecting chylomicron and chylomicron remnant clearanceWILLIAMS, C. M.Atherosclerosis. 1998, Vol 141, pp S87-S92, issn 0021-9150, SUP1Conference Paper

Identification of a functional receptor differing from the LDL receptor that catabolizes chylomicron remnant in Hep G2 cellsHAYASHI, K; NAKASHIMA, K; HATTORI, Y et al.Atherosclerosis. 1993, Vol 104, Num 1-2, pp 105-115, issn 0021-9150Article

Medium-chain fatty acids : evidence for incorporation into chylomicron triglycerides in humanSWIFT, L. L; HILL, J. O; PETERS, J. C et al.The American journal of clinical nutrition. 1990, Vol 52, Num 5, pp 834-836, issn 0002-9165, 3 p.Article

Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in miceHARRIS, H. W; GRUNFELD, C; FEINGOLD, K. R et al.The Journal of clinical investigation. 1990, Vol 86, Num 3, pp 696-702, issn 0021-9738Article

Competition between chylomicrons and their remnants for plasma removal: a study with artificial emulsion models of chylomicronsOLIVEIRA, H. C. F; HIRATA, M. H; REDGRAVE, T. G et al.Biochimica et biophysica acta. 1988, Vol 958, Num 2, pp 211-217, issn 0006-3002Article

Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting stateSMITH, D; WATTS, G. F; DANE-STEWART, C et al.European journal of clinical investigation. 1999, Vol 29, Num 3, pp 204-209, issn 0014-2972Article

Chylomicronemia syndromeCHAIT, A; BRUNZELL, J. D.Advances in internal medicine. 1992, Vol 37, pp 249-273, issn 0065-2822Article

Steatorrhea and disorders of chylomicron synthesis and secretionLEVY, E; CHOURAQUI, J.-P; ROY, C. C et al.The Pediatric clinics of North America. 1988, Vol 35, Num 1, pp 53-67, issn 0031-3955Article

The GTPase ARFRP1 controls the lipidation of chylomicrons in the Golgi of the intestinal epitheliumJASCHKE, Alexander; CHUNG, Bomee; HEEREN, Joerg et al.Human molecular genetics (Print). 2012, Vol 21, Num 14, pp 3128-3142, issn 0964-6906, 15 p.Article

The quantitative separation of chylomicrons and chylomicron remnants by column chromatographyFELTS, J. M.Biochimica et biophysica acta. 1987, Vol 918, Num 1, pp 93-96, issn 0006-3002Article

Novel Missense Mutations of SAR1B Gene in an Infant With Chylomicron Retention DiseaseTREEPONGKARUNA, Suporn; CHONGVIRIYAPHAN, Nalinee; SUTHUTVORAVUT, Umaporn et al.Journal of pediatric gastroenterology and nutrition. 2009, Vol 48, Num 3, pp 370-373, issn 0277-2116, 4 p.Article